Logo image of NNOX

NANO-X IMAGING LTD (NNOX) Stock Fundamental Analysis

NASDAQ:NNOX - Nasdaq - IL0011681371 - Common Stock - Currency: USD

6.3  -0.1 (-1.56%)

After market: 6.31 +0.01 (+0.16%)

Fundamental Rating

3

NNOX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 108 industry peers in the Health Care Providers & Services industry. NNOX has a great financial health rating, but its profitability evaluates not so good. While showing a medium growth rate, NNOX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

NNOX had negative earnings in the past year.
In the past year NNOX has reported a negative cash flow from operations.
In the past 5 years NNOX always reported negative net income.
NNOX had a negative operating cash flow in each of the past 5 years.
NNOX Yearly Net Income VS EBIT VS OCF VS FCFNNOX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 -20M -40M -60M -80M -100M

1.2 Ratios

With a Return On Assets value of -27.02%, NNOX is not doing good in the industry: 82.24% of the companies in the same industry are doing better.
NNOX has a worse Return On Equity (-30.33%) than 65.42% of its industry peers.
Industry RankSector Rank
ROA -27.02%
ROE -30.33%
ROIC N/A
ROA(3y)-29.8%
ROA(5y)-59.51%
ROE(3y)-34.83%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NNOX Yearly ROA, ROE, ROICNNOX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 100 -100 200

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for NNOX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NNOX Yearly Profit, Operating, Gross MarginsNNOX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 -1K -2K -3K -4K

More info and screens

8

2. Health

2.1 Basic Checks

NNOX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NNOX has been increased compared to 1 year ago.
The number of shares outstanding for NNOX has been increased compared to 5 years ago.
The debt/assets ratio for NNOX is higher compared to a year ago.
NNOX Yearly Shares OutstandingNNOX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
NNOX Yearly Total Debt VS Total AssetsNNOX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

NNOX has an Altman-Z score of 7.87. This indicates that NNOX is financially healthy and has little risk of bankruptcy at the moment.
NNOX has a better Altman-Z score (7.87) than 93.46% of its industry peers.
NNOX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 7.87
ROIC/WACCN/A
WACC9.06%
NNOX Yearly LT Debt VS Equity VS FCFNNOX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 100M 200M

2.3 Liquidity

NNOX has a Current Ratio of 4.64. This indicates that NNOX is financially healthy and has no problem in meeting its short term obligations.
NNOX has a better Current ratio (4.64) than 94.39% of its industry peers.
A Quick Ratio of 4.56 indicates that NNOX has no problem at all paying its short term obligations.
The Quick ratio of NNOX (4.56) is better than 93.46% of its industry peers.
Industry RankSector Rank
Current Ratio 4.64
Quick Ratio 4.56
NNOX Yearly Current Assets VS Current LiabilitesNNOX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 56.00% over the past year.
The Revenue has grown by 10.80% in the past year. This is quite good.
EPS 1Y (TTM)56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%59.46%
Revenue 1Y (TTM)10.8%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%22.27%

3.2 Future

The Earnings Per Share is expected to grow by 29.45% on average over the next years. This is a very strong growth
Based on estimates for the next years, NNOX will show a very strong growth in Revenue. The Revenue will grow by 86.14% on average per year.
EPS Next Y15.16%
EPS Next 2Y15.24%
EPS Next 3Y22.55%
EPS Next 5Y29.45%
Revenue Next Year15.12%
Revenue Next 2Y70.98%
Revenue Next 3Y104.91%
Revenue Next 5Y86.14%

3.3 Evolution

NNOX Yearly Revenue VS EstimatesNNOX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
NNOX Yearly EPS VS EstimatesNNOX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 4 6 8 10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

NNOX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NNOX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NNOX Price Earnings VS Forward Price EarningsNNOX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NNOX Per share dataNNOX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

A more expensive valuation may be justified as NNOX's earnings are expected to grow with 22.55% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.24%
EPS Next 3Y22.55%

More info and screens

0

5. Dividend

5.1 Amount

NNOX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NANO-X IMAGING LTD

NASDAQ:NNOX (2/21/2025, 8:00:01 PM)

After market: 6.31 +0.01 (+0.16%)

6.3

-0.1 (-1.56%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-21 2024-11-21/bmo
Earnings (Next)03-04 2025-03-04/amc
Inst Owners19.19%
Inst Owner Change27.02%
Ins Owners4.54%
Ins Owner ChangeN/A
Market Cap368.55M
Analysts84
Price Target15.3 (142.86%)
Short Float %12.87%
Short Ratio1.67
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)14.03%
Min EPS beat(2)-4.07%
Max EPS beat(2)32.13%
EPS beat(4)3
Avg EPS beat(4)22.67%
Min EPS beat(4)-4.07%
Max EPS beat(4)41.82%
EPS beat(8)4
Avg EPS beat(8)-0.03%
EPS beat(12)5
Avg EPS beat(12)-9.45%
EPS beat(16)8
Avg EPS beat(16)-4.06%
Revenue beat(2)0
Avg Revenue beat(2)-24.29%
Min Revenue beat(2)-32.68%
Max Revenue beat(2)-15.9%
Revenue beat(4)0
Avg Revenue beat(4)-27.16%
Min Revenue beat(4)-43.3%
Max Revenue beat(4)-15.9%
Revenue beat(8)0
Avg Revenue beat(8)-24.1%
Revenue beat(12)1
Avg Revenue beat(12)-14.29%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)21.62%
PT rev (3m)12.5%
EPS NQ rev (1m)-4.62%
EPS NQ rev (3m)-4.62%
EPS NY rev (1m)2.55%
EPS NY rev (3m)-1.14%
Revenue NQ rev (1m)-8.2%
Revenue NQ rev (3m)-22.77%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-8.13%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 34.51
P/FCF N/A
P/OCF N/A
P/B 2.25
P/tB 4.04
EV/EBITDA N/A
EPS(TTM)-0.77
EYN/A
EPS(NY)-0.72
Fwd EYN/A
FCF(TTM)-0.7
FCFYN/A
OCF(TTM)-0.66
OCFYN/A
SpS0.18
BVpS2.8
TBVpS1.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.02%
ROE -30.33%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-29.8%
ROA(5y)-59.51%
ROE(3y)-34.83%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 18.98%
Cap/Sales 21.14%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.64
Quick Ratio 4.56
Altman-Z 7.87
F-Score4
WACC9.06%
ROIC/WACCN/A
Cap/Depr(3y)367.19%
Cap/Depr(5y)1599.93%
Cap/Sales(3y)632.82%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%59.46%
EPS Next Y15.16%
EPS Next 2Y15.24%
EPS Next 3Y22.55%
EPS Next 5Y29.45%
Revenue 1Y (TTM)10.8%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%22.27%
Revenue Next Year15.12%
Revenue Next 2Y70.98%
Revenue Next 3Y104.91%
Revenue Next 5Y86.14%
EBIT growth 1Y0.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y35.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y22.58%
OCF growth 3YN/A
OCF growth 5YN/A